This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

BD Vacutainer Plus 2.7 mL Citrate Blood Collection Tube

Starting date:
November 19, 2012
Posting date:
January 7, 2013
Type of communication:
Medical Device Recall
Subcategory:
Medical Device
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Medical Devices
Audience:
General Public (GP), Healthcare Professionals, Hospitals
Identification number:
RA-16631

Recalled Products

A. BD Vacutainer Plus 2.7 mL Citrate Blood Collection Tube

Reason

There is evidence that in a portion of the affected lot there is a cross-contamination with lithium heparin, in a concentration not exceeding 1.2 iu per milliliter in plasma obtained from properly filled tubes (note: this value was obtained from healthy subjects using a limited number of tubes from the affected lot). The internal investigation completed by bd indicates that this contaminant can adversely affect coagulation results. Erroneous results may lead to inappropriate decisions regarding patient care. For a full listing of assays that may be adversely affected by the lithium heparin contaminant, please contact the manufacturer.

Affected products

A. BD Vacutainer Plus 2.7 mL Citrate Blood Collection Tube

Lot or serial number

2180434

Model or catalog number

363083

Companies
Manufacturer

Becton Dickinson and Company